T40.712 Poisoning by cannabis, intentional self-harm

Name of the Condition

• Poisoning by cannabis, intentional self-harm

Summary

This ICD code applies to cases where an individual intentionally exposes themselves to an excessive amount of cannabis with the intent to cause self-harm. It covers acute toxicity resulting from deliberate misuse or overdose of cannabis products, including ingestion, inhalation, or other routes of exposure. The code is specific to self-inflicted harm rather than accidental or therapeutic use.

Causes

Intentional self-harm involving cannabis typically results from deliberate overdose, often driven by underlying mental health conditions, suicidal ideation, or substance use disorders. It may involve consuming high-potency products, such as edibles or concentrates, in quantities exceeding safe limits. The act is intentional, distinguishing it from accidental exposure or therapeutic use.

Risk Factors

• History of suicidal behavior or ideation
• Co-occurring mental health disorders (e.g., depression, anxiety)
• Substance use disorders, particularly involving cannabis or other drugs
• Access to high-potency cannabis products
• Lack of social support or isolation

Symptoms

• Severe dizziness, confusion, or disorientation
• Intense anxiety, panic attacks, or paranoia
• Nausea, vomiting, or abdominal pain
• Tachycardia (increased heart rate) or palpitations
• Profound drowsiness, lethargy, or loss of consciousness
• Psychotic symptoms (e.g., hallucinations, delusions)

Diagnosis

Diagnosis requires a clinical evaluation, including a detailed history of cannabis exposure and intent. Toxicology screens may confirm cannabinoid presence, though symptom severity may not correlate directly with test results. Healthcare providers assess for self-harm indicators and underlying mental health conditions. Physical exams and vital sign monitoring support diagnosis.

Treatment Options

• Immediate medical stabilization, including airway management if needed
• Supportive care (e.g., hydration, monitoring of vital signs)
• Benzodiazepines for severe anxiety, agitation, or seizures
• Activated charcoal in cases of recent ingestion (within 1–2 hours)
• Referral to mental health services for crisis intervention and long-term support

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Most cases resolve with supportive care, but severe toxicity may require hospitalization. Follow-up includes mental health evaluation to address underlying risks and prevent recurrence. Long-term monitoring for substance use or mental health concerns is recommended.

Complications

• Respiratory depression or failure in severe cases
• Cardiovascular events (e.g., arrhythmias, hypertension)
• Psychiatric complications (e.g., prolonged psychosis, depression)
• Accidental injury due to impaired coordination or judgment
• Worsening of pre-existing mental health conditions

Lifestyle & Prevention

• Secure storage of cannabis products to prevent access
• Education on safe use and potency awareness for users
• Mental health support and crisis intervention resources
• Avoidance of high-potency products in at-risk individuals
• Regular screening for substance use and suicidal ideation

When to Seek Professional Help

Seek immediate medical attention if symptoms of overdose occur, such as severe confusion, difficulty breathing, loss of consciousness, or signs of self-harm. Prompt care is critical to prevent complications. Mental health support should be sought for ongoing suicidal thoughts or substance use concerns.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes the code from accidental or therapeutic use. Include details of exposure (e.g., product type, route, quantity) and any associated mental health or substance use factors. Ensure the code is assigned only when self-harm is confirmed, aligning with clinical documentation.